NYSE ARCA | ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index.
It will normally invest at least 80% of its net assets in securities that comprise the underlying index.
The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of theU. S.
Food and Drug Administration clinical trials.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 5.51% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.36% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.66% |
VRNA | Verona Pharma PLC ADR | Healthcare | Biotechnology | 4.66% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.60% |
RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.38% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.07% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 3.93% |
VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.74% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.59% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.56% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 3.36% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 3.14% |
ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.08% |
RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 2.98% |
IMVT | Immunovant Inc | Healthcare | Biotechnology | 2.89% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.88% |
CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 2.75% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.73% |
PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 2.72% |